These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 12120265)

  • 21. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of the Pringle maneuver on the pancreas: can octreotide be protective?
    Unalp OV; Aydin U; Yazici P; Nart D; Yenisey C; Kavak T; Zeytunlu M; Coker A
    JOP; 2009 May; 10(3):284-91. PubMed ID: 19454821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
    Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Octreotide prevents L-asparaginase-induced pancreatic injury in rats.
    Suzuki M; Shimizu T; Kudo T; Shoji H; Ohtsuka Y; Yamashiro Y
    Exp Hematol; 2008 Feb; 36(2):172-80. PubMed ID: 18023522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery.
    Bassi C; Falconi M; Pederzoli P
    Gut; 1994; 35(3 Suppl):S20-2. PubMed ID: 7911443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of somatostatin in 67 consecutive pancreatectomies: a randomized clinical trial.
    Katsourakis A; Oikonomou L; Chatzitheoklitos E; Noussios G; Pitiakoudis M; Polychronidis A; Simopoulos K; Sioga A
    Clin Exp Gastroenterol; 2010; 3():179-83. PubMed ID: 21694864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula.
    Ohta T; Nagakawa T; Mori K; Kanno M; Kayahara M; Ueno K; Miyazaki I
    Int J Pancreatol; 1992 Jun; 11(3):185-9. PubMed ID: 1517658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octreotide hardens the pancreas.
    Foitzik T; Gock M; Schramm C; Prall F; Klar E
    Langenbecks Arch Surg; 2006 Apr; 391(2):108-12. PubMed ID: 16568326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group.
    Bassi C; Falconi M; Lombardi D; Briani G; Vesentini S; Camboni MG; Pederzoli P
    Digestion; 1994; 55 Suppl 1():41-7. PubMed ID: 8132136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IS PROPHYLACTIC USE OF OCTREOTIDE BENEFICIAL IN PREVENTING COMPLICATIONS AFTER PANCREATIC SURGERY?
    Chaudhry R
    Med J Armed Forces India; 2000 Oct; 56(4):314-315. PubMed ID: 28790750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine structure of exocrine cells of the pancreas.
    CHALLICE CE; LACY D
    Nature; 1954 Dec; 174(4442):1150-1. PubMed ID: 13223771
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of parenteral and early intrajejunal nutrition on pancreatic digestive enzyme synthesis, storage and discharge in dog models of acute pancreatitis.
    Qin HL; Su ZD; Hu LG; Ding ZX; Lin QT
    World J Gastroenterol; 2007 Feb; 13(7):1123-8. PubMed ID: 17373751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas.
    Falconi M; Caldiron E; Zancanaro C; Benati D; Talamini G; Bassi C; Pederzoli P
    Pancreatology; 2001; 1(1):30-5. PubMed ID: 12120265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of octreotide on pancreatic endocrine function in partial pancreatectomy.
    Presti M; Niehoff M; Rioux J; Burton F; Garvin P
    J Surg Res; 1996 Mar; 61(2):449-53. PubMed ID: 8656623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does prophylactic administration of somatostatin decrease the rates of complications after pancreatic resection?: A clinical and electron microscopy study.
    Katsourakis A; Zezos P; Noussios G; Kouklakis G; Chatzitheoklitos E; Simopoulos K; Pitiakoudis M
    Pancreas; 2013 Jan; 42(1):37-41. PubMed ID: 22836860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide, a new somatostatin analogue.
    Katz MD; Erstad BL
    Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.